>
Surgical Science Sweden AB logo

SUS - Surgical Science Sweden AB Share Price

SEK127 1.8  1.4%

Last Trade - 16/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £375.9m
Enterprise Value £368.7m
Revenue £8.99m
Position in Universe 556th / 1831
Bullish
Bearish
Unlock SUS Revenue
Momentum
Relative Strength (%)
1m +8.27%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.08%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
104.6
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
46.1 51.8 57.3 65.7 101.5 104.8 181 236.5 +17.8%
+15.1 +101.3 -0.10 +145.8 +47.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, SurgicalScience Sweden AB revenues increased 3% to SEK104.8M. Netincome increased 24% to SEK15.6M. Revenues reflect Americas(Region) segment increase of 40% to SEK58.8M, Other Europesegment increase of 26% to SEK27.7M. Basic Earnings perShare excluding Extraordinary Items remained flat atSEK0.45.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SUS Revenue Unlock SUS Revenue

Net Income

SUS Net Income Unlock SUS Revenue

Normalised EPS

SUS Normalised EPS Unlock SUS Revenue

PE Ratio Range

SUS PE Ratio Range Unlock SUS Revenue

Dividend Yield Range

SUS Dividend Yield Range Unlock SUS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SUS EPS Forecasts Unlock SUS Revenue
Profile Summary

Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since June 19, 2017
No. of Shareholders: 2,841
No. of Employees: 61
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 34,494,760
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SUS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SUS
Upcoming Events for SUS
Tuesday 11th May, 2021
Q1 2021 Surgical Science Sweden AB Earnings Release
Friday 20th August, 2021
Q2 2021 Surgical Science Sweden AB Earnings Release
Frequently Asked Questions for Surgical Science Sweden AB
What is the Surgical Science Sweden AB share price?

As of 16/04/21, shares in Surgical Science Sweden AB are trading at SEK127, giving the company a market capitalisation of £375.9m. This share price information is delayed by 15 minutes.

How has the Surgical Science Sweden AB share price performed this year?

Shares in Surgical Science Sweden AB are currently trading at SEK127 and the price has moved by 0.120k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Surgical Science Sweden AB price has moved by 70.26% over the past year.

What are the analyst and broker recommendations for Surgical Science Sweden AB?

Of the analysts with advisory recommendations for Surgical Science Sweden AB, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Surgical Science Sweden AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Surgical Science Sweden AB next release its financial results?

Surgical Science Sweden AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Surgical Science Sweden AB dividend yield?

Surgical Science Sweden AB does not currently pay a dividend.

Does Surgical Science Sweden AB pay a dividend?

Surgical Science Sweden AB does not currently pay a dividend.

When does Surgical Science Sweden AB next pay dividends?

Surgical Science Sweden AB does not currently pay a dividend.

How do I buy Surgical Science Sweden AB shares?

To buy shares in Surgical Science Sweden AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Surgical Science Sweden AB?

Shares in Surgical Science Sweden AB are currently trading at SEK127, giving the company a market capitalisation of £375.9m.

Where are Surgical Science Sweden AB shares listed? Where are Surgical Science Sweden AB shares listed?

Here are the trading details for Surgical Science Sweden AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: SUS
What kind of share is Surgical Science Sweden AB?

Based on an overall assessment of its quality, value and momentum, Surgical Science Sweden AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Surgical Science Sweden AB share price forecast 2021?

Shares in Surgical Science Sweden AB are currently priced at SEK127. At that level they are trading at 18.11% discount to the analyst consensus target price of 0.00.

Analysts covering Surgical Science Sweden AB currently have a consensus Earnings Per Share (EPS) forecast of 1.065 for the next financial year.

How can I tell whether the Surgical Science Sweden AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgical Science Sweden AB. Over the past six months, the relative strength of its shares against the market has been 9.08%. At the current price of SEK127, shares in Surgical Science Sweden AB are trading at 34.29% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Surgical Science Sweden AB PE Ratio?

The Surgical Science Sweden AB PE ratio based on its reported earnings over the past 12 months is 0.293k. The shares are currently trading at SEK127.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Surgical Science Sweden AB?

We were unable to find the directors for Surgical Science Sweden AB.

Who are the major shareholders of Surgical Science Sweden AB?

Here are the top five shareholders of Surgical Science Sweden AB based on the size of their shareholding:

Handelsbanken Asset Management Investment Advisor/Hedge Fund
Percentage owned: 8.58% (3.25m shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 7.86% (2.98m shares)
Handelsbanken Svenska Smabolagsfond Mutual Fund
Percentage owned: 4.08% (1.55m shares)
TIN Fonder Investment Advisor
Percentage owned: 3.26% (1.24m shares)
Ny Teknik Mutual Fund
Percentage owned: 3.26% (1.24m shares)
Similar to SUS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.